General Information of Drug (ID: DM9U1HV)

Drug Name
5-fluoro-1H-indole-2-carboxylic acid Drug Info
Synonyms
5-Fluoroindole-2-carboxylic acid; 399-76-8; 5-Fluoro-1H-indole-2-carboxylic acid; 2-Carboxy-5-fluoroindole; 1H-Indole-2-carboxylic acid, 5-fluoro-; CHEMBL23507; MLS000080089; WTXBRZCVLDTWLP-UHFFFAOYSA-N; MFCD00005612; SMR000037735; 5-Fluoroindole-2-carboxylic acid, 98%; Spectrum_001495; EINECS 206-919-5; PubChem1683; SpecPlus_000678; Spectrum5_001733; Opera_ID_1340; Spectrum4_001182; Spectrum3_001043; Spectrum2_001469; ACMC-209j9k; AC1Q4NE3; Lopac-265128; cid_1820; AC1Q73TI; AC1L1CB9; AC1Q73TJ; Lopac0_000071; Oprea1_012690
Indication
Disease Entry ICD 11 Status REF
Glioma 2A00.0 Investigative [1]
Melanoma 2C30 Investigative [1]
Cross-matching ID
PubChem CID
1820
ChEBI ID
CHEBI:111276
CAS Number
CAS 399-76-8
TTD Drug ID
DM9U1HV

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Drug(s) Targeting AP endonuclease 1 (APEX1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
APX3330 DMU6NBO Diabetic retinopathy 9B71.0 Phase 2 [2]
APX-3330 DMXIMQT Solid tumour/cancer 2A00-2F9Z Phase 1 [3]
1,3-bis(1,3-benzothiazol-2-ylthio)acetone DMP86R3 Glioma 2A00.0 Investigative [1]
3-benzofuran-2-yl-2-benzothiazol-2-yl-3-oxo-propanenitrile DMWLIK1 Glioma 2A00.0 Investigative [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
AP endonuclease 1 (APEX1) TTHGL48 APEX1_HUMAN Inhibitor [1]

References

1 Development and evaluation of human AP endonuclease inhibitors in melanoma and glioma cell lines. Br J Cancer. 2011 Feb 15;104(4):653-63.
2 Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic. NPJ Precis Oncol. 2017;1:19.
3 Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo. Vision Res. 2011 Jan;51(1):93-100.